Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycemic agents (APOLLO): an open randomised controlled trial. - Bretzel,R.G.; Nuber,U.; Landgraf,W. (Lancet, 2008)